On the public citation graph
Data-driven strategies for drug repurposing: insights, recommendations, and case studies
0 signed · 53 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2020.1166openalex-snapshot
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
inferredcites →https://doi.org/10.1007/978-1-0716-2624-5_7openalex-snapshot
Proteome Integral Solubility Alteration (PISA) for High-Throughput Ligand Target Deconvolution with Increased Statistical Significance and Reduced Sample Amount
inferredcites →https://doi.org/10.1007/s43440-023-00501-4openalex-snapshot
Polypharmacology: promises and new drugs in 2022
inferredcites →https://doi.org/10.1016/j.canlet.2025.217441openalex-snapshot
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer
inferredcites →https://doi.org/10.1016/j.cell.2017.10.049openalex-snapshot
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
inferredcites →https://doi.org/10.1016/s0037-1963(03)70015-8openalex-snapshot
Imatinib: A targeted clinical drug development
inferredcites →https://doi.org/10.1016/s0140-6736(01)06535-7openalex-snapshot
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
inferredcites →https://doi.org/10.1021/acsomega.1c05203openalex-snapshot
TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow
inferredcites →https://doi.org/10.1038/ncomms10331openalex-snapshot
Network-based in silico drug efficacy screening
inferredcites →https://doi.org/10.1038/nrg2918openalex-snapshot
Network medicine: a network-based approach to human disease
inferredcites →https://doi.org/10.1038/s41467-025-62407-4openalex-snapshot
A broad-spectrum antibiotic targets multiple-drug-resistant bacteria with dual binding targets and no detectable resistance
inferredcites →https://doi.org/10.1038/s41540-022-00221-0openalex-snapshot
Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects
inferredcites →https://doi.org/10.1038/s41570-021-00313-1openalex-snapshot
Towards the sustainable discovery and development of new antibiotics
inferredcites →https://doi.org/10.1038/s41573-025-01164-xopenalex-snapshot
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
inferredcites →https://doi.org/10.1038/s41577-020-00421-xopenalex-snapshot
After 62 years of regulating immunity, dexamethasone meets COVID-19
inferredcites →https://doi.org/10.1038/s41586-021-03819-2openalex-snapshot
Highly accurate protein structure prediction with AlphaFold
inferredcites →https://doi.org/10.1038/s43586-021-00084-5openalex-snapshot
DNA-encoded chemical libraries
inferredcites →https://doi.org/10.1056/nejm198012183032516openalex-snapshot
Reversal of Baldness in Patient Receiving Minoxidil for Hypertension
inferredcites →https://doi.org/10.1080/17460441.2021.1883585openalex-snapshot
Artificial intelligence, machine learning, and drug repurposing in cancer
inferredcites →https://doi.org/10.1080/17460441.2024.2430955openalex-snapshot
Validation guidelines for drug-target prediction methods
inferredcites →https://doi.org/10.1093/bib/bbaa003openalex-snapshot
Exploration of databases and methods supporting drug repurposing: a comprehensive survey
inferredcites →https://doi.org/10.1093/bioinformatics/btae496openalex-snapshot
Attention-based approach to predict drug–target interactions across seven target superfamilies
inferredcites →https://doi.org/10.1093/database/bay083openalex-snapshot
Drug Target Commons 2.0: a community platform for systematic analysis of drug–target interaction profiles
inferredcites →https://doi.org/10.1093/database/bay092openalex-snapshot
An end-to-end deep learning architecture for extracting protein–protein interactions affected by genetic mutations
inferredcites →https://doi.org/10.1093/nar/gkad1004openalex-snapshot
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods
inferredcites →https://doi.org/10.1093/nar/gkad944openalex-snapshot
The IUPHAR/BPS Guide to PHARMACOLOGY in 2024
inferredcites →https://doi.org/10.1093/nar/gkad976openalex-snapshot
DrugBank 6.0: the DrugBank Knowledgebase for 2024
inferredcites →https://doi.org/10.1093/nar/gkae1075openalex-snapshot
BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data
inferredcites →https://doi.org/10.1093/nar/gkae909openalex-snapshot
KEGG: biological systems database as a model of the real world
inferredcites →https://doi.org/10.1093/nar/gkw1092openalex-snapshot
KEGG: new perspectives on genomes, pathways, diseases and drugs
inferredcites →https://doi.org/10.1111/j.1476-5381.2010.01127.xopenalex-snapshot
Principles of early drug discovery
inferredcites →https://doi.org/10.1126/science.ade2574openalex-snapshot
Evolutionary-scale prediction of atomic-level protein structure with a language model
inferredcites →https://doi.org/10.1182/blood.v21.6.699.699openalex-snapshot
The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful Therapy
inferredcites →https://doi.org/10.1186/1758-2946-5-3openalex-snapshot
UniChem: a unified chemical structure cross-referencing and identifier tracking system
inferredcites →https://doi.org/10.1602/neurorx.2.4.541openalex-snapshot
Medicinal chemical properties of successful central nervous system drugs
inferredcites →https://doi.org/10.2217/pme-2020-0183openalex-snapshot
Pharmacogenomic Considerations for Repurposing of Dexamethasone as a Potential Drug Against SARS-CoV-2 Infection
inferredcites →https://doi.org/10.3389/fmed.2024.1352803openalex-snapshot
Drug repurposing for rare: progress and opportunities for the rare disease community
inferredcites →https://doi.org/10.3389/fmicb.2023.1279159openalex-snapshot
A cooperativity between virus and bacteria during respiratory infections
inferredcites →https://doi.org/10.3390/antibiotics10030326openalex-snapshot
Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review
inferredcites →https://doi.org/10.7497/j.issn.2095-3941.2014.01.001openalex-snapshot
Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1007/s10822-026-00798-2openalex-snapshot
AI-driven drug–target interaction prediction: current progress, challenges, and future roadmap for precision medicine
inferred← citeshttps://doi.org/10.1007/s13042-026-03153-xopenalex-snapshot
CLAT-DTA: a collaborative attention-based approach for drug-target binding affinity prediction
inferred← citeshttps://doi.org/10.1016/j.sbi.2026.103401openalex-snapshot
Predicting targets and off-targets of small molecule drugs
inferred← citeshttps://doi.org/10.1021/acs.jcim.6c02172openalex-snapshot
Evaluation of the Complementarity of Three Major Databases of Protein–Ligand Binding Affinity Data
inferred← citeshttps://doi.org/10.1038/s41419-026-08757-3openalex-snapshot
TRIM25 promotes glioblastoma progression by stabilizing HIF-1α expression in normoxia through K11/K29 polyubiquitination
inferred← citeshttps://doi.org/10.1038/s42004-026-01945-4openalex-snapshot
Enabling multi-target drug discovery through latent evolutionary optimization and synthesis-aware prioritization (EVOSYNTH)
inferred← citeshttps://doi.org/10.1093/bib/bbag488openalex-snapshot
DLRNA-BERTa: a transformer approach for predicting molecule-RNA binding affinities
inferred← citeshttps://doi.org/10.1109/tcbbio.2026.3675301openalex-snapshot
TriCloud: Drug-Target-Disease Ternary Network for Drug Repositioning Research Based on Point Cloud Modeling
inferred← citeshttps://doi.org/10.1155/mi/9028037openalex-snapshot
Single‐Cell Transcriptomics Reveals Biomarkers for NK Cell Dysfunction in Endometriosis‐Associated Immune Dysregulation
inferred← citeshttps://doi.org/10.1186/s12859-026-06376-5openalex-snapshot
Design and evaluation of semantically-valid negative samples integration techniques for scalable semi-automated drug repurposing prediction pipelines in rare disease research
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.